Kohjin Bio Co.,Ltd.
| Code | Sector | Market |
|---|---|---|
| 177A | Chemicals | Growth |
| Date of listing approval | 2024/03/22 |
|---|---|
| Expected Date | 2024/04/25 |
| Lead Underwriter | Nomura Securities Co., Ltd |
| Description |
| Listed Shares(total) | 977,500 |
|---|---|
| Trading Unit | 100 |
| New Shares | 850,000 |
| Existing Shares | 127,500¡Êonly O.A.¡Ë |
| Shares Outstanding | PreIPO 4,165,000.00 |
| PostIPO 5,015,000.00 | |
| Paid Up Capital | PreIPO Y426,656,000 |
| PostIPO Y1,169,556,000 | |
| Expected Pricing Date | 2024/04/05 |
| Book Building Start | 2024/04/09 |
| Book Building End | 2024/04/15 |
| Fix Date | 2024/04/16 |
| Offering Starts | 2024/04/17 |
| Offering Ends | 2024/04/22 |
| Expect Pricing | Y1,840-Y1,900 |
| Notional PER (based on previous period) |
9.24-9.54 |
| Notional PER(based on results forecast) | 26.50-27.37 |
| Offering Price | Y1,900 |
| Offering Price PER (based on previous period) |
26.50-27.37 |
| Offering Price PBR (based on previous period) |
2.62 |
| Offering Price PER (based on results forecast) |
27.37 |
| Use of Funds Raised |
Financial Data
Units:Y1,000
| Fiscal Year End:2021/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 3,251,321 |
| Current Profit | - | 665,762 |
| Net Profit | - | 685,074 |
| Net Assets | - | 1,418,904 |
| Fiscal Year End:2022/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | 3,947,089 | 3,622,295 |
| Current Profit | 917,837 | 841,840 |
| Net Profit | 587,675 | 564,269 |
| Net Assets | 2,216,895 | 2,002,942 |
| Fiscal Year End:2023/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | 4,742,992 | 4,406,871 |
| Current Profit | 1,244,391 | 1,116,671 |
| Net Profit | 829,790 | 751,221 |
| Net Assets | 3,017,830 | 2,712,308 |
| Recent Quarter 2023/12 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | 3,544,575 | - |
| Current Profit | 397,839 | - |
| Net Profit | 207,138 | - |
| Net Assets | 3,184,261 | - |
| Results Forecast 2024/03 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | 4,724,000 | - |
| Current Profit | 560,000 | - |
| Net Profit | 289,000 | - |
| Net Assets | - | - |
Per Share Units:Y1
| Fiscal Year End:2021/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 10.00 | |
| Net Earning | - | - |
| Equity | 202.39 | 412.20 |
| Fiscal Year End:2022/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 10.00 | |
| Net Earning | 173.50 | 532.27 |
| Equity | 166.59 | 480.90 |
| Fiscal Year End:2023/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 19.00 | |
| Net Earning | 199.23 | 724.57 |
| Equity | 180.37 | 651.21 |
| Fiscal Year End:Recent Quarter 2023/12 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | ||
| Net Earning | 49.73 | - |
| Equity | - | - |
| Fiscal Year End:Results Forecast 2024/03 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 14.00 | |
| Net Earning | 69.43 | - |
| Equity | - | - |
Comment
| ¢£Over allotment(127,500) |
Consolidated Subsidiaries
| Name | Address |
|---|
Underwriters
| Allocation | Underwriter | Tel |
|---|---|---|
| 0% | Nomura | 03-3211-1811 |
| 90% | Nomura Securities Co., Ltd | 03-3211-1811 |
| 3% | Mizuho Securities Co., Ltd | 03-5208-3210 |
| 3% | SMBC Nikko Securities Inc. | 03-5644-3111 |
| 3% | Musashi Securities Co.,Ltd | 048-644-0634 |
| 1% | SBI SECURITIES Co.,Ltd. | 03-5562-7210 |
Data
| Date of incorporation | 1981/04/20 |
|---|---|
| Company address | Saitama 350-0214 |
| Telephone | 049-284-3781 |
| President | |
| Homepage | https://kohjin-bio.jp/ |
| Auditor | KPMG AZSA LLC |
| Major Shareholders | |
|---|---|
| Shareholder Name | Ratio |
| 86.62% | |
| 53.05% | |
| 10.00% | |
| 6.48% | |
| 4.23% | |
| 3.36% | |
| 2.88% | |
| 2.40% | |
| 2.40% | |
| 2.40% | |
| 1.92% | |
| Number of Employees | 133 as of 2024/02/29 |
|---|---|
| Birth Date of Representative | 1949/05/23 |